CHRN

Identity

Formerly traded as EKSO.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

• 2026-05-04share offering or dilution eventrecentOpen filing ↗
  “…for the Common Stock will change to 170924 104 and the Company will change its name to “ChronoScale Corporation.” A copy of the…”
  +1 more passage from the same document

  • “…Form 8-K (this “Current Report”) and is incorporated herein by reference. Item 1.01. Entry into a Material Definitive Agreement.…”
• 2026-04-28share offering or dilution eventrecentOpen filing ↗
  “…due to a lower accounts receivable balance, lower inventory balance, and a higher accounts payable balance, partially offset by a…”
  +1 more passage from the same document

  • “…exercised for cash its Existing Investor Warrants to purchase an aggregate of 653 shares (the “Existing Investor Warrant…”
• 2026-04-28listing compliance noticerecentOpen filing ↗
  “…Company received a written notice from the Nasdaq Listing Qualifications staff of the Nasdaq Stock Market LLC (“Nasdaq”) informing…”
  +1 more passage from the same document

  • “…the Company that because the minimum bid price for the Company’s common stock listed on the Nasdaq Capital Market was below…”
• 2026-04-28capital return (buybacks/dividends)recentOpen filing ↗
  “…at the September 2024 Public Offering issuance date. The Series A Warrants are, and the Series B Warrants were, equity classified…”
  +1 more passage from the same document

  • “…capital and was recorded at the October 2025 Offering issuance date. The October 2025 Placement Agent Warrant is equity classified…”
• 2026-04-28reverse splitrecentOpen filing ↗
  “…of Contents Ekso Bionics Holdings, Inc. Notes to Condensed Consolidated Financial Statements ($ and share amounts in thousands,…”
  +1 more passage from the same document

  • “…the minimum bid price for the Company’s common stock listed on the Nasdaq Capital Market was below $1.00 per share over the…”
• 2026-02-23share offering or dilution eventrecentOpen filing ↗
  “…in the Personal Health market for use in a non-Company-sponsored single clinical study. Subject to clinical and patient feedback…”
  +1 more passage from the same document

  • “…a higher prepaid expenses and other current assets balance, a lower accrued liabilities balance, and a lower deferred revenues,…”
• 2026-02-23listing compliance noticerecentOpen filing ↗
  “…of $1.00 per share. On December 12, 2024, we received a written notice (the “Notice”) from the Nasdaq Listing Qualifications…”
  +1 more passage from the same document

  • “…Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) informing us that because the minimum bid price of our common…”
• 2026-02-23capital return (buybacks/dividends)recentOpen filing ↗
  “…recorded at the March 2025 Inducement Warrant issuance date. The Inducement Warrant is equity classified because it (i) is a…”
  +1 more passage from the same document

  • “…at the September 2024 Public Offering issuance date. The Series A Warrants are, and the Series B Warrants were, equity classified…”

4 older entries not shown

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

Reverse splits in 5 years

1 reverse split in 5 years (1:15 on Jun 2, 2025) · 1:15 cumulative

The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.